| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |